Active substance
Etamsylate
- SFDA 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| Dicynone | 500 mg | Capsule · Oral use | 20 Blister | SAR 50.60 | NCE · Prescription | OM Pharma SA | Valid |
| DICYNONE TAB 250MG | 250 mg | Tablet · Oral use | 20 Blister | SAR 27.95 | Biological · Prescription | OM PHARMA | Withdrawn by MAH · Not Marketed |
| DICYNONE TAB 250MG | 250 mg | Tablet · Oral use | 100 Blister | SAR 120.70 | Biological · Prescription | OM PHARMA | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ANESTHESIA-SUPPORTIVE AGENTS/ MANAGEMENT OF BLEEDING
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.